ABPO.US Abpro Holdings, Inc.

Healthcare Biotechnology USA Stocks
0.5100 USD
Close of Nov 13, 2026
0.0870 7.34
Market cap
USD 3.01M
P/E
0.3x
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is ABPO.US undervalued?

Graham number

The Graham number of Abpro Holdings, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Abpro Holdings, Inc. fundamental analysis

No fundamental analysis for Abpro Holdings, Inc. yet.

Abpro Holdings, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Abpro Holdings, Inc.

Abpro Holdings, Inc., a biotechnology company, focuses on the development of novel antibodies using discovery and engineering platforms for immuno-oncology, ophthalmology, and infectious disease in the United States. Its platforms include DiversImmune, an antibody discovery platform that generates a diverse collection of proprietary antibodies against clinically validated and novel targets; and MultiMab, an engineering platform that provides flexibility to combine antibody b…

Full company profile